Literature DB >> 23276881

A four-CRD C-type lectin from Chlamys farreri mediating nonself-recognition with broader spectrum and opsonization.

Mengmeng Huang1, Lingling Wang, Jialong Yang, Huan Zhang, Leilei Wang, Linsheng Song.   

Abstract

C-type lectins are a superfamily of Ca(2+)-dependent carbohydrate-recognition proteins consisting of at least one carbohydrate-recognition domain (CRD), which participate in nonself-recognition and clearance of invaders. In invertebrate, some multidomain C-type lectins have been identified, but their relative functions and binding mechanism are still meager. In the present study, A C-type lectin (CfLec-4) with four CRDs from Chlamys farreri was selected to investigate its possible function in innate immunity. The mRNA expression of CfLec-4 in hemocytes was significantly up-regulated (P<0.01) after the stimulations of β-glucan, LPS or PGN, and reached the highest expression level at 3, 6, 12 h post-stimulation, which was 27.9-, 22.6- or 47.9-fold of that in blank group, respectively. Immunohistochemistry assay with polyclonal antibody specific for CfLec-4 revealed that the endogenous CfLec-4 was mainly located in the hepatopancreas, kidney and gonad of the scallops. The recombinant CfLec-4 (rCflec-4) could bind LPS, PGN, glucan and mannose in vitro, but could not bind LTA. Furthermore, rCflec-4 displayed a broader bacteria binding spectrum towards Gram-positive bacteria Staphylococcus aureus and Micrococcus luteus as well as Gram-negative bacteria Escherichia coli, Vibrio anguillarum and fungi Pichia pastoris. Meanwhile, rCfLec-4 could significantly (P<0.01) enhance the phagocytosis of hemocytes in vitro. The results clearly suggested that four-CRD containing CfLec-4 not only served as PRR with wider recognition spectrum, but also functioned as an opsonin participating in the clearance of invaders in scallops. It could be inferred that the diversity and complexity of CRDs in C-type lectins endowed these receptors with comprehensive recognition spectrum and multiple immune functions against complex living environment.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23276881     DOI: 10.1016/j.dci.2012.12.002

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  5 in total

1.  CfLec-3 from scallop: an entrance to non-self recognition mechanism of invertebrate C-type lectin.

Authors:  Jialong Yang; Mengmeng Huang; Huan Zhang; Lingling Wang; Hao Wang; Leilei Wang; Limei Qiu; Linsheng Song
Journal:  Sci Rep       Date:  2015-05-15       Impact factor: 4.379

2.  Bivalve-specific gene expansion in the pearl oyster genome: implications of adaptation to a sessile lifestyle.

Authors:  Takeshi Takeuchi; Ryo Koyanagi; Fuki Gyoja; Miyuki Kanda; Kanako Hisata; Manabu Fujie; Hiroki Goto; Shinichi Yamasaki; Kiyohito Nagai; Yoshiaki Morino; Hiroshi Miyamoto; Kazuyoshi Endo; Hirotoshi Endo; Hiromichi Nagasawa; Shigeharu Kinoshita; Shuichi Asakawa; Shugo Watabe; Noriyuki Satoh; Takeshi Kawashima
Journal:  Zoological Lett       Date:  2016-02-18       Impact factor: 2.836

Review 3.  Microbial Diseases of Bivalve Mollusks: Infections, Immunology and Antimicrobial Defense.

Authors:  Carla Zannella; Francesco Mosca; Francesca Mariani; Gianluigi Franci; Veronica Folliero; Marilena Galdiero; Pietro Giorgio Tiscar; Massimiliano Galdiero
Journal:  Mar Drugs       Date:  2017-06-17       Impact factor: 5.118

4.  Identification of a Novel Pattern Recognition Receptor DM9 Domain Containing Protein 4 as a Marker for Pro-Hemocyte of Pacific Oyster Crassostrea gigas.

Authors:  Zhihao Jia; Shuai Jiang; Mengqiang Wang; Xiudan Wang; Yu Liu; Zhao Lv; Xiaorui Song; Yiqun Li; Lingling Wang; Linsheng Song
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

5.  A C-Type Lectin Highly Expressed in Portunus trituberculatus Intestine Functions in AMP Regulation and Prophenoloxidase Activation.

Authors:  Yuan Liu; Yue Su; Ao Zhang; Zhaoxia Cui
Journal:  Antibiotics (Basel)       Date:  2021-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.